Dr. Clay Siegall is a soldier in the war to defeat cancer. It is a war in which he has been engaged for decades. Over the years he has had his share of victories. But the war isn’t over, so Dr. Siegall is using his biotech company, Seattle Genetics, to create better weapons to battle cancer in all its forms. He is also collaborating with numerous companies worldwide to improve the quality and effectiveness of the care and treatments cancer patients receive. His goal is to create technologies and techniques that can destroy cancerous cells without damaging the adjoining healthy tissue.
A graduate of the University of Maryland and George Washington University, Clay Siegall has a bachelor’s degree in Zoology and a PhD in Genetics. He has also worked wit some of the top companies worldwide involved in cancer research and the development of targeted cancer treatments. The development of treatments that can be deployed with surgical precision is one of Dr. Siegall’s goals. And the staff at Seattle Genetics is hard at work creating an entire arsenal of them. Dr. Siegall’s ability to create an environment at Seattle Genetics that encourages rigorous research, innovative thinking and a commitment to results-oriented collaboration is what sets the company apart.
The talented staff members love what they do and it shows in the quality of the results they get. Since the company was formed in 1998, they’ve become a leader in the development of powerful, targeted treatments that have been very successful in eradicating cancerous cells and tissue with little to no collateral damage to surrounding tissue of the host. As a result, the cancer treatment therapies created by Dr. Siegall and the staff at Seattle Genetics are being used on the frontline of the fight against cancer all over the world with remarkable results.
But even as Dr. Siegall and his team win major battles, they understand the war against cancer is not over. They’ve created better cancer fighting weapons than have been seen in many years and are committed to continuing to fight until cancer is no longer a threat.